2012 FDA drug approvals

被引：0

作者：

Asher Mullard

机构：

来源：

Nature Reviews Drug Discovery | 2013年 / 12卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

FDA drug approval bonanza sees cancer and orphan drugs on top again.

引用

页码：87 / 90

页数：3

共 50 条

[1] 2012 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (02) : 87 - 90
[2] 2013 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2014, 13 : 85 - 89
[3] 2014 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2015, 14 : 77 - 81
[4] 2016 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 73 - 76
[5] 2015 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2016, 15 : 73 - 76
[6] Recent FDA drug approvals
Naccari, Christopher
[J]. CNS SPECTRUMS, 2008, 13 (06) : 466 - 466
[7] 2008 FDA drug approvals
Hughes, Bethan
[J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 93 - 96
[8] 2011 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2012, 11 (2) : 91 - 94
[9] 2008 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2009, 8 : 93 - 96
[10] 2009 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2010, 9 : 89 - 92